METTL3 and retinoblastoma: More subsequent studies have also demonstrated that METTL3 is significantly upregulated in hepatocellular carcinoma (HCC) (20), colorectal cancer (CRC) (18), retinoblastoma (RB) (20), and multiple solid tumors.